Freenome
A Senior Machine Learning Research Engineer at Freenome designs and builds scalable deep learning pipelines and AI/ML systems within a cloud environment. The role involves optimizing hardware utilization, managing distributed computing platforms, and collaborating with scientists and engineers to accelerate cancer early detection models. This position requires bridging engineering and scientific teams to ensure reliable, reproducible, and high-performance model training and inference.
Headquarters
Brisbane, California, United States
Company Size
501-1000 employees
Founded
2014
Freenome is a publicly traded biotech company developing blood-based screening tests to detect cancer early and make screening more accessible. The company's Personalized Cancer Detection approach combines multiomics technology with artificial intelligence and machine learning to identify cancer-specific signals from a standard blood draw. Freenome's SimpleScreen portfolio, including the FDA-approved SimpleScreen CRC for colorectal cancer screening, represents its growing suite of non-invasive cancer detection products.
Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform
Dec 5, 2025
Cancer detection firm Freenome to go public via $330 million SPAC deal
Dec 5, 2025
Cancer blood test maker Freenome going public with $330M SPAC
Dec 5, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Freenome.
13% above the average for this role
Freenome teams up with Roche for cancer screening tests
Nov 19, 2025